Enteral Syringe Market
Enteral syringes are majorly used for administering drugs and nutritional therapy through oral, rectal or sublingual route of administration. They are commonly used in hospitals, clinics, and homes and are available in range of 1ml to 60 ml. Newly launched enteral syringes are designed and manufactured to meet latest international standard ISO-80369-3. Drugs can be directly placed into the gastro-intestinal tract through enteral route. Enteral syringes are most widely used for delivering oral liquid medication and nutrition. These syringes works like enteral feedings in its function and end use. Enteral syringes come with purple plunger, which indicates that that the medication in the syringe must be administered via enteral route. Purple color is used in order to separate these syringes from IV syringes. These syringes are utilized for various purpose such as correct measurement of liquid medicine to be administered to patient in situation where dose cannot be accurately measured using a medicine cup or spoon, for administering medicine to infants and young children, and administering controlled drug liquid medicines. These syringes are available in different types such as single use syringes and home use syringes.
The global enteral syringe market size was valued at US$ 575.6 million in 2017 and is expected to witness a CAGR of 4.9% over the forecast period (2018 – 2026).
Figure 1. Global Enteral Syringe Market Value (US$ Mn), by Region, 2017
Source – Coherent Market Insights Report
Increasing number of critical care and neonatal intensive care unit admissions and increasing geriatric population are expected to drive growth of the global enteral syringe market.
Increasing number of critical care and neonatal intensive care unit admissions is expected to drive growth of the global enteral syringes market. This is owing to inability of patients admitted to critical care and newborns admitted to neonatal intensive care (due to premature birth or other complications) to swallow medicine or take nutrition. According to statistics given by Bliss Organization, over 95,000 newborns are admitted to neonatal units in the U.K, annually due to premature birth (before 37 weeks of pregnancy) or due to full term (after 37 weeks) yet sick birth. Moreover, according to same source around 1 in every 8 newborns in the U.K are admitted to neonatal units, annually.
Furthermore, increasing geriatric population is expected to boost the market growth over the forecast period. People above 60 years of age are more prone to illness or injuries that often require hospital admissions and nutritional therapy and medication administration via enteral syringe. According to United Nations report: World Population Prospect-The 2017 Revision, worldwide geriatric population is expected to increase from 962 million in 2017 (13% of worldwide population) to 1.3 billion by 2030 and will reach to 2.1 billion by 2050. According to same source, worldwide geriatric population is increasing at a rate of 3%, annually and around all regions, except Africa, are expected to register geriatric population of over 25% by 2050.
Figure 2. Global Enteral Syringe Market, Segmentation, 2017
Source – Coherent Market Insights Report
Updated regulatory guidelines for enhanced safety features associated with enteral syringe are expected to propel growth of the market
Regulatory guidelines for design and manufacturing of enteral devices including enteral syringe were recently updated by various regulatory bodies. In 2015, new design standards were introduced in enteral feeding sets, enteral syringes, and enteral feeding tubes referred as ENFit. ENFit is a new connection standard that is developed by an international group of clinicians, manufacturers body Global Enteral Device Supplier Association (GEDSA), and regulators under aegis of Stay Connected initiative to prevent tubing misconnections and patient injury. Tubing misconnection occurs when enteral devices are connected to non-enteral devices such as IV lines, urinary catheters, and ventilator tubing. Global Enteral Device Supplier Association (GEDSA) promotes safe use of enteral devices including syringes. Market players that comply with ENFit standard design are receiving 510(k) clearance from the U.S Food and Drug Administration (U.S. FDA). For instance, in 2016, NeoMed and Medtronic received the U.S FDA 510(k) clearance for low dose tip ENFit syringes. NeoMed has offered royalty-free access of its design to all syringe manufacturers. Therefore, several manufacturers can implement this design standard to promote safe use of these devices, which in turn is expected to increase adoption of enteral syringes.
Key players operating in the global enteral syringe market include, B. Braun Melsungen AG, GBUK Enteral Ltd., Thermo Fischer, Inc., Koninklijke Philips N.V., Miktell Ltd., Baxter International, Inc., Cardinal Health, Inc., Terumo Corporation, Kentec Medical, Inc., Vygon S.A., and others.
Enteral syringes are most commonly used for patients that are admitted in hospital, critical care unit, and NICU. Such patients are unable to ingest medicines and food, therefore, enteral syringes helps in administration of medicines and food. Moreover, Enteral syringes assists in precise measurement of medicines. These syringes are available in purple plunger in order to distinguish them from other types of syringes.
Major factor driving growth of the enteral syringe market is increasing prevalence of chronic diseases such as cancer, which often results in hospital admissions in late stage of the disease. These patients are unable to ingest any kind of food and medicines, therefore, enteral syringes are preferred in such situations. According to a report by International Agency for Research on Cancer, titled GLOBOSCAN, September 2018, around 18.1 million new cancer cases and 9.6 million cancer deaths were recorded in 2018, worldwide. Moreover, same source mentions that, one out of every five men and one out of every six women worldwide suffer from cancer during their lifetime and one out of every eight men and one out of every 11 women die from the disease. The total number of people surviving within 5 years of a cancer diagnosis, called the 5-year prevalence, is around 43.8 million, worldwide. Another major factor for growth of this market is changed syringe design adopted internationally which ensures extra safety and allows wider use of enteral syringe devices worldwide. In the year 2018, several manufacturers launched ENFit compliant enteral syringe in the market which would help in expansion of the market
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 25 market data tables and 30 figures on "Enteral Syringe Market - Global forecast to 2026”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.